Key Highlights
- Shares of Quantum Cyber (QUCY) exploded more than 73% following the announcement of an exclusive intellectual property licensing deal with BP United Inc. covering advanced drone systems
- The agreement provides QUCY with exclusive access to BP United’s autonomous drone technology, featuring a sky defense platform operational beyond 25 kilometers
- Federal defense appropriations under the current administration target approximately $55 billion for autonomous aerial systems and drone warfare in fiscal year 2027, a dramatic increase from the previous year’s ~$225 million allocation
- QUCY currently trades around $0.32 per share with approximately $4 million in market capitalization and generated $540,000 in trailing twelve-month revenues
- Management indicated forthcoming announcements regarding additional technology partnerships, intellectual property applications, and quantum antenna innovations
Quantum Cyber (QUCY) represents a micro-cap company positioning itself aggressively in the defense drone sector. Shares rocketed over 73% during Tuesday’s trading session after the firm revealed it had finalized an exclusive intellectual property licensing arrangement with BP United Inc., a Florida-based developer specializing in autonomous unmanned aerial vehicle systems.

Through this arrangement, Quantum Cyber obtains exclusive licensing privileges to BP United’s comprehensive drone technology assets. Central to the portfolio is an autonomous sky defense platform engineered to function at distances surpassing 25 kilometers.
The system operates with complete autonomy across all flight phases — launch, route navigation, and touchdown — designed specifically for reconnaissance, interception, and payload transport operations. All communications utilize encrypted protocols for security.
BP United has committed under the agreement’s terms to establish a commercial supply framework for manufacturing and delivering these autonomous defense systems.
Massive Federal Defense Investment
This transaction unfolds against a landscape of unprecedented shifts in federal military expenditure. The current administration has proposed approximately $55 billion dedicated to drone warfare and autonomous combat systems within the fiscal 2027 defense appropriations. This represents a monumental leap from the prior year’s roughly $225 million allocation — marking the most substantial year-over-year expansion in drone procurement throughout American military history.
Chief Executive David Lazar addressed this funding environment directly. “The Trump administration has elevated autonomous warfare to a critical national security priority, and the $55 billion budget allocation sends an unmistakable message to the marketplace,” Lazar stated.
Chief Financial Officer Bill Caragol emphasized the strategic advantages of the deal’s framework, noting it simultaneously secures intellectual property rights and establishes commercial production capabilities through a unified transaction. He characterized it as “a potentially scalable route from platform manufacturing through revenue realization.”
Quantum Cyber describes its strategic vision as developing an integrated “System-of-Systems” architecture — consolidating drone combat capabilities, counter-unmanned aircraft systems, autonomous mine clearance, command infrastructure, and quantum-enhanced defense technologies within a single publicly-traded entity on the Nasdaq exchange.
The organization leverages combat-proven technologies from Israeli and Ukrainian battlefield environments while utilizing American capital markets to finance platform expansion.
Significant Challenges Remain
The dramatic stock movement requires proper perspective. QUCY shares currently trade at merely $0.32 with total market capitalization hovering near $4 million. The enterprise recorded just $540,000 in total revenue throughout the trailing twelve-month period while continuing to consume capital reserves.
Prior to Tuesday’s surge, the stock had plummeted 87% over the preceding twelve months.
Quantum Cyber previously operated under the name Mainz Biomed. The company executed a comprehensive rebrand and modified its Nasdaq ticker symbol to QUCY, reflecting its strategic pivot toward defense and autonomous technology sectors. Leadership recently strengthened with the appointment of Robert P. Liscouski as Board Chairman.
CEO David Lazar has demonstrated personal conviction through $6 million in direct equity investments via private placement transactions, including a recent $3 million commitment.
Additional corporate developments are anticipated. Management has signaled intentions to submit supplementary patent applications and broaden its technology portfolio, with particular emphasis on quantum antenna system advancements.





